[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Biosimilar Market Set to Grow Further, Expects Rockville Research in Its Report Published at MarketPublishers.com

07 Feb 2017 • by Natalie Aster

LONDON – The world’s market for biosimilars is set to experience further growth in the coming years. There is an array of factors that will encourage it, and expiries of biological parents are some of the major ones. Some other important drivers are cost saving and the rising usage of biosimilars in the treatment of chronic diseases.

Yet, the marketplace faces certain challenges like high costs associated with development, biosimilars’ lower adoption rate, regulatory pressures, and more.

When it comes to the competitive landscape, large globals dominate the new biosimilars landscape. Some of major companies worth mentioning are TEVA, Hospira, Sandoz and Biocad, to name a few. In the meantime, pharmerging markets enjoy growing attention.

In-demand research report “Global Biosimilar Market by Classes, Human Growth Hormone, Granulocyte- Colony Stimulating Factor, Monoclonal Antibody and Interferon & Markets (Developed & Emerging) - Industry Outlook 2020” worked out by Rockville Research offers a comprehensive discussion of the global market for biosimilars. The study provides a 360-degree overview of this evolving space.

It estimates the actual sizing of the marketplace and forecasts its changes in the years to come. The report discloses market shares owned by regions, applications and product pipelines.

The research study covers the following product categories: insulin, EPO, MAB, IFN, and more. It scrutinizes developed and emerging markets.

The research report examines pricing trends. The study comprises the SWOT analysis and contains the market attractiveness index.

It sheds light on driving forces of this space. The report focuses on challenges of the marketplace, its trends and developments.

The research study highlights the competitive landscape. It discloses market shares owned by drugs and competitors.

The research report profiles companies that lead global race. The study comprises future projections for this marketplace through 2020.

Report Highlights:

  • all-round overview of the marketplace;
  • coverage of driving forces and challenges;
  • insights into trends and developments;
  • details on pricing trends;
  • investigation of the competitive landscape;
  • future outlook;
  • and more.

More insightful studies by Rockville Research can be found at its page


The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected]

Analytics & News

Weekly Digest